Hereditary Hemorrhagic Telangiectasia
📧 Sign up to get email alerts when something new happens for Hereditary Hemorrhagic Telangiectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Sirolimus for Nosebleeds in HHT [Phase 2]
Phase 2 clinical trial results for sirolimus in treating nosebleeds associated with hereditary hemorrhagic telangiectasia have been complete…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Ultra-low-dose Chest CT for HHT
A Mayo Clinic-sponsored trial evaluating ultra-low-dose chest CT for hereditary hemorrhagic telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
The document notes the completion of a clinical trial evaluating cerebral hemorrhage risk in hereditary hemorrhagic telangiectasia, sponsore…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) [Phase 2, Phase 3]
This document reports an ongoing Phase 2/Phase 3 clinical trial evaluating pazopanib for hereditary hemorrhagic telangiectasia-related epist…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network
A clinical trial update reports on the efficacy and tolerability of Bevacizumab for severe liver involvement with high cardiac output in her…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study [Phase 2]
Phase II trial evaluating bevacizumab for efficacy and safety in hereditary hemorrhagic telangiectasia with severe hepatic vascular malforma…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement [NA]
A clinical trial update notes that a stress-echography study in a patient with hereditary hemorrhagic telangiectasia and hepatic involvement…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO
A completed DISQUO study update describing how symptoms impact quality of life for people with hereditary hemorrhagic telangiectasia (HHT).
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient [NA]
This completed trial evaluated the diagnostic value of an ultra-low-dose thoracic scanner for detecting pulmonary arteriovenous malformation…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) [Phase 2]
A Phase 2 trial evaluating timolol nasal spray for epistaxis in hereditary hemorrhagic telangiectasia has completed, reporting on its effica…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). [Phase 3]
Phase 3 trial evaluating bevacizumab for efficacy and safety in reducing severe bleeding in hereditary hemorrhagic telangiectasia has comple…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. [Phase 2]
Phase 2 trial evaluating oral nintedanib for epistaxis in hereditary hemorrhagic telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose [Phase 1, Phase 2]
Phase 1/2 trial evaluating intranasal bevacizumab for nasal telangiectasia in hereditary hemorrhagic telangiectasia to identify an effective…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Doxycycline for Hereditary Hemorrhagic Telangiectasia [Phase 2]
This clinical trial update indicates that the Phase 2 study of doxycycline for hereditary hemorrhagic telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 study evaluating tacrolimus for hereditary hemorrhagic telangiectasia-related epistaxis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Sirolimus for Nosebleeds in HHT [Phase 2]
Sirolimus was studied in a Phase 2 trial for nosebleeds associated with hereditary hemorrhagic telangiectasia, and the study has completed e…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Hereditary Haemorrhagic Telangiectasia Flight Safety Study
A completed clinical trial evaluating flight safety in individuals with hereditary hemorrhagic telangiectasia has posted its results. The st…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Pomalidomide for the Treatment of Bleeding in HHT [Phase 2]
Phase 2 trial of pomalidomide for reducing bleeding in hereditary hemorrhagic telangiectasia has completed and results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept [Phase 1, Phase 2]
Phase 1/2 trial evaluating a topical anti-angiogenic therapy for hereditary hemorrhagic telangiectasia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia [Phase 1, Phase 2]
A clinical trial evaluating pazopanib for epistaxis in hereditary hemorrhagic telangiectasia (HHT) at Phase 1/2 stages. Current status is un…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients [Phase 3]
Phase 3 trial completed evaluating propranolol for reducing epistaxis in hereditary hemorrhagic telangiectasia.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia [Phase 2]
Phase 2 trial update for timolol gel addressing epistaxis in hereditary hemorrhagic telangiectasia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Intranasal Bevacizumab for HHT-Related Epistaxis [Phase 4]
Phase 4 trial update on intranasal bevacizumab for hereditary hemorrhagic telangiectasia (HHT) with epistaxis has completed; results posted …
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 trial evaluating submucosal bevacizumab for recurrent epistaxis in hereditary hemorrhagic telangiectasia (HHT) has completed, with r…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]
Phase 2 trial investigating topical bevacizumab for managing recurrent epistaxis in patients with hereditary hemorrhagic telangiectasia is c…